A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and tobacco use.

In this installment in our series about diseases preventable by vaccination, we examine hepatitis A and why protection from ...

The Standing Committee on National Health Services, Regulations and Coordination (NHSR&C) emphasised that diabetes, HIV, ...

Haryana launches a strengthened framework under the National Viral Hepatitis Control Programme, focusing on enforceable reporting, integrated digital surveillance, maternal and high-risk group ...

A Norwich woman has spoken out for the first time about the guilt she feels after surviving Hepatitis C contracted through.

Chandigarh, Haryana has decided to comprehensively strengthen surveillance, reporting and treatment monitoring of viral hepatitis under the National Viral Hepatitis Control Programme.

Among rural people with chronic HCV infection and a history of injection drug use, a mobile telemedicine-based intervention vs enhanced usual care improves treatment initiation and cure rates.

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...

The inquiry into what has been dubbed the worst treatment disaster in the history of the NHS is to officially close in March.

Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.

Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...